Francesco Clementi - Major publications#
Grady SR, Moretti M, Zoli M, Marks MJ, Zanardi A, Pucci L, Clementi F, Gotti C. (2009) Rodent habenulo—interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release.
J Neurosci 29: 2272-2282.
Benfante R, Flora A, Di Lascio S, Cargnin F, Longhi R, Colombo S, Clementi F, Fornasari D. (2007) Transcription factor PHOXZA regulates the human alpha3 nicotinic receptor subunit gene promoter.
JBiol Chem 282: 13290-13302.
Gotti C, Moretti M, Bohr I, Ziabreva I, Vailati S, Longhi R, Riganti L, Gaimarri A, McKeith IG, Perry RH, Aarsland D, Larsen JP, Sher E, Beattie R, Clementi F, Court J, A. (2006) Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinsons disease and dementia with Lewy bodies by immunoprecipitation.
Neurobiol Dis. 23: 481-489.
Gotti C, Clementi F (2004) Neuronal nicotinic receptors: from structure to pathology.
Prog Neurobiol 74:363-396.
Flora A, Luechetti H, Benfante R, Goridis C, Clementi F, Fornasari D. (2001) Sp proteins and Phox2b regulate the expression of the human Phox2a gene.
J.Neurosci.21: 7037-7045.
Gotti C., Esparis Ogando A., Hanke W., Sclilue R., Moretti M., Clementi F. (1991) Purification and characterization of an α-Bungarotoxin receptor that forms a functional nicotinic channel.
Proc. Natl. Acad. Sci. USA, 88:3258-3262.
Sher E., Gotti C., Canal N., Scoppetta C., Piccolo G., Evoli A. and Clementi F. (1989) Specificity of calcium channel autoantibodies in Lambeit-Eaton syndrome.
Lancet I1:640-643.
Gotti C, Sher E, Cabrini D, Bondiolotti G, Wanke E, Mancinelli E, Clementi F. (1987) Cholinergic receptors, ion channels, neurotransmitter synthesis, and neurite outgrowth are independently regulated during the in vitro differentiation of a human neuroblastoina cell line.
Differentiation 34: 144-155.
Conti-Tronconi BM, Morgutti M, Sghirlanzoni A, Clementi F. (1979) Cellular immune response to acetylcholine receptor in myasthenia gravis: 1. Relevance to clinical course and pathogenesis. 11. Thymectomy and corticosteroids.
Neurology 29: 496-501; 734-738.
Clementi F, Palade GE (1969) Intestinal capillaries. I. Permeability to peroxidase and ferritin. II. Structural effects of EDTA and histamine.
J Cell Biol 42: 33-58; 706-714.